Steven J. Schoch's most recent trade in Zura Bio Ltd - Ordinary Shares - Class A was a trade of 51,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zura Bio Ltd (Class A) | Steven J. Schoch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 51,000 | 51,000 | - | - | Share Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Steven J. Schoch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Steven J. Schoch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 7,652 | 7,652 | - | - | Employee Share Option (Right to Buy) | |
| 23andMe Holding Co Ordinary | Steven J. Schoch | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.33 per share. | 20 Aug 2022 | 4,782 | 211,663 | - | 3.3 | 15,924 | Class A Common Stock |
| 23andMe Holding Co Ordinary | Steven J. Schoch | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.82 per share. | 01 Jun 2022 | 4,782 | 216,445 | - | 2.8 | 13,485 | Class A Common Stock |